FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2018/04/012924 [Registered on: 02/04/2018] Trial Registered Prospectively
Last Modified On: 27/03/2018
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Siddha 
Study Design  Other 
Public Title of Study   To study the effect of drug VELLARUGU CHOORANAM on Gunman (peptic ulcer) 
Scientific Title of Study   A prospective open labeled non randomized phase II clinical trial to assess therapeutic efficacy of the Siddha formulation Vellarugu chooranam for the treatment of Erigunmam (Peptic Ulcer Disease) 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  M MUTHUMARI 
Designation  PG Student 
Affiliation  Government siddha medical college and hospital 
Address  Op number 10 PG Dept of Pothu Maruthuvam Government siddha medical college and hospital Palayamkottai

Tirunelveli
TAMIL NADU
627002
India 
Phone  8220606063  
Fax    
Email  dr.muthumari23@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr T KOMALAVALLI MD siddha PhD 
Designation  Associate Professor  
Affiliation  Government siddha medical college and hospital 
Address  Department of Pothu maruthuvam Government siddha medical college and hospital palayamkottai

Tirunelveli
TAMIL NADU
627002
India 
Phone  9788122691  
Fax    
Email  komalaarumugam1@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr T KOMALAVALLI MD siddha PhD 
Designation  Associate Professor  
Affiliation  Government siddha medical college and hospital 
Address  Department of Pothu maruthuvam Government siddha medical college and hospital Palayamkottai

Tirunelveli
TAMIL NADU
627002
India 
Phone  9788122691  
Fax    
Email  komalaarumugam1@gmail.com  
 
Source of Monetary or Material Support  
IPD and OPD Government Siddha Medical College and Hospital Palayamkottai 
Library Government Siddha​ Medical College and Hospital Palayamkottai 
 
Primary Sponsor  
Name  Dr S Neelavathi MD siddha PhD 
Address  Principal government siddha medical college and hospital palayamkottai 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
M MUTHUMARI  Government Siddha Medical College and Hospital  Op number 10 PG Department of Pothu Maruthuvam Government Siddha Medical College and Hospital Palayamkottai
Tirunelveli
TAMIL NADU 
8220606063

dr.muthumari23@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  ERIGUNMAM,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Not applicable   Not applicable  
Intervention  Vellarugu chooranam  30mg/Kg/BW/daily bid with warm water orally for 30 days 
 
Inclusion Criteria  
Age From  20.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  Patient with appropriate symptoms of burning pain in upper abdomen nausea waterbrash headache flatulence dizziness excessive sweating loss of body weight lack of food intake neuritic pain cough patient who are willing to sign consent form and undergo laboratory investigations 
 
ExclusionCriteria 
Details  Pregnant and lactating women haemetemesis Malena pancreatitis inflammatory bowel disease recent malignancy or radiation therapy  
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
The therapeutic efficacy of trial drug VELLARUGU CHOORANAM on ERIGUNMAM  30 days 
 
Secondary Outcome  
Outcome  TimePoints 
Evaluation of siddha diagnostic parameters  30 days 
 
Target Sample Size   Total Sample Size="40"
Sample Size from India="40" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   05/04/2018 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="3"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   Not yet 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary   The study is prospective open Labeled non randomized phase II clinical trial to evaluate the therapeutic efficacy of trial drug Vellarugu Chooranam 30mg/kg/BW/two times a day with warm water for 30 days in 40 patients during the trial period of 15 months that will be conducted in Government Siddha Medical college and hospital Palayamkottai Tamilnadu The primary outcome will be the therapeutic efficacy of trial drug Vellarugu Chooranam on ERIGUNMAM The secondary outcome will be the evaluation of Siddha diagnostic parameters 
Close